Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AIDS RESEARCH MAXIMIZATION WOULD BE AIDED BY PERMANENT AND RESTRUCTURED R&D AND ORPHAN DRUG TAX CREDITS, BIO TELLS NATIONAL TASK FORCE ON AIDS SUBCMTE.

Executive Summary

AIDS should be designated as an orphan disease in order to encourage industry research for the condition, the Biotechnology Industry Organization told a subcommittee meeting of the National Task Force on AIDS Drug Development April 25 in Bethesda, Md.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel